Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C18H22BrNO |
| Molecular Weight | 348.277 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)CCOC(C)(C1=CC=CC=C1)C2=CC=C(Br)C=C2
InChI
InChIKey=URSRSKSNFPUKGH-UHFFFAOYSA-N
InChI=1S/C18H22BrNO/c1-18(21-14-13-20(2)3,15-7-5-4-6-8-15)16-9-11-17(19)12-10-16/h4-12H,13-14H2,1-3H3
| Molecular Formula | C18H22BrNO |
| Molecular Weight | 348.277 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL231 Sources: https://www.ncbi.nlm.nih.gov/pubmed/7758143 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| H(1)- antihistamines and activated blood platelets. | 2006-04 |
|
| Cationic amphiphilic drugs and platelet phospholipase A(2) (cPLA(2)). | 2002-02-15 |
|
| Titrimetric and spectrophotometric assay of some antihistamines through the determination of the chloride of their hydrochlorides. | 2002-01 |
|
| Vitrification of mouse oocytes using a nylon loop. | 2001-03 |
|
| Pharmacological intervention with platelet phospholipase A2. | 2001 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 09:53:16 GMT 2025
by
admin
on
Wed Apr 02 09:53:16 GMT 2025
|
| Record UNII |
HH0KD7Z416
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29578
Created by
admin on Wed Apr 02 09:53:16 GMT 2025 , Edited by admin on Wed Apr 02 09:53:16 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
998
Created by
admin on Wed Apr 02 09:53:16 GMT 2025 , Edited by admin on Wed Apr 02 09:53:16 GMT 2025
|
PRIMARY | |||
|
C81150
Created by
admin on Wed Apr 02 09:53:16 GMT 2025 , Edited by admin on Wed Apr 02 09:53:16 GMT 2025
|
PRIMARY | |||
|
SUB06500MIG
Created by
admin on Wed Apr 02 09:53:16 GMT 2025 , Edited by admin on Wed Apr 02 09:53:16 GMT 2025
|
PRIMARY | |||
|
DTXSID60863198
Created by
admin on Wed Apr 02 09:53:16 GMT 2025 , Edited by admin on Wed Apr 02 09:53:16 GMT 2025
|
PRIMARY | |||
|
1784
Created by
admin on Wed Apr 02 09:53:16 GMT 2025 , Edited by admin on Wed Apr 02 09:53:16 GMT 2025
|
PRIMARY | |||
|
C005715
Created by
admin on Wed Apr 02 09:53:16 GMT 2025 , Edited by admin on Wed Apr 02 09:53:16 GMT 2025
|
PRIMARY | |||
|
19105
Created by
admin on Wed Apr 02 09:53:16 GMT 2025 , Edited by admin on Wed Apr 02 09:53:16 GMT 2025
|
PRIMARY | |||
|
m1131
Created by
admin on Wed Apr 02 09:53:16 GMT 2025 , Edited by admin on Wed Apr 02 09:53:16 GMT 2025
|
PRIMARY | Merck Index | ||
|
3565-72-8
Created by
admin on Wed Apr 02 09:53:16 GMT 2025 , Edited by admin on Wed Apr 02 09:53:16 GMT 2025
|
PRIMARY | |||
|
CHEMBL2110819
Created by
admin on Wed Apr 02 09:53:16 GMT 2025 , Edited by admin on Wed Apr 02 09:53:16 GMT 2025
|
PRIMARY | |||
|
100000080773
Created by
admin on Wed Apr 02 09:53:16 GMT 2025 , Edited by admin on Wed Apr 02 09:53:16 GMT 2025
|
PRIMARY | |||
|
HH0KD7Z416
Created by
admin on Wed Apr 02 09:53:16 GMT 2025 , Edited by admin on Wed Apr 02 09:53:16 GMT 2025
|
PRIMARY | |||
|
EMBRAMINE
Created by
admin on Wed Apr 02 09:53:16 GMT 2025 , Edited by admin on Wed Apr 02 09:53:16 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT | |||
|
|
ENANTIOMER -> RACEMATE | |||
|
|
SALT/SOLVATE -> PARENT | |||
|
|
ENANTIOMER -> RACEMATE | |||
|
TARGET -> INHIBITOR |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |